EUVIMEDEUVIMED entdecken
Crossref

Three-Dimensional Modeling of Solid Tumors and Their Microenvironment to Evaluate T Cell Therapy Efficacy In Vitro

Ronja Pscheid iD, Esther Drent iD, Judith Wienke iD, Josephine G M Strijker iD, Mark Throsby, Jan J Molenaar

The Journal of Immunology · 2023

DOI: 10.4049/jimmunol.2200573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Ronja Pscheid und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gadeta B.V., Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: EC | Horizon 2020 Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy development for solid tumors remains challenging, partially due to a lack of reproducible, cost-effective in vitro three-dimensional (3D) models to mimic the heterogeneous and complex tumor microenvironment. Here, we investigate the cellular anti-tumor reactivity of αβ T cells engineered to express a defined γδ TCR (TEG A3). For that purpose, we developed a 3D cytotoxicity assay targeting cell line–derived spheroids or patient-derived tumor organoids formed in serum-free media. Tumor cell lysis by TEG A3 was monitored using the Incucyte S3 live-cell imaging system with the apoptosis marker caspase 3/7 green and endpoint readouts of IFN-γ secretion in the supernatant. The 3D cytotoxicity assay model system was able to adequately demonstrate TEG A3 reactivity toward targets expressing an isoform of CD277 (CD277J). To obtain a more complex heterogeneous tumor microenvironment, patient-derived organoids were mixed with unmatched patient-derived fibroblasts or matched cancer-associated fibroblasts. In all assays, we demonstrated the tumor target specificity of TEG A3, lysing tumor cells within 48 h. Our study demonstrates the utility of complex 3D cytotoxicity assay model systems incorporating the tumor microenvironment in the functional evaluation of T cell–based adoptive immunotherapy, providing a useful platform for early-stage preclinical development of immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansT-LymphocytesImmunotherapy, AdoptiveImmunotherapyCell- and Tissue-Based TherapyTumor Microenvironment

Autor:innen und Institutionen

  • Gadeta B.V., Utrecht, the Netherlands.
  • Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.

ORCID-Profile: Ronja Pscheid, Esther Drent, Judith Wienke, Josephine G M Strijker

Förderung

  • EC | Horizon 2020 Framework Programme

Zitieren

APA

Pscheid, R., Drent, E., Wienke, J., Strijker, J. G. M., Throsby, M., & Molenaar, J. J. (2023). Three-Dimensional Modeling of Solid Tumors and Their Microenvironment to Evaluate T Cell Therapy Efficacy In Vitro. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200573

Vancouver

Pscheid R, Drent E, Wienke J, Strijker JGM, Throsby M, Molenaar JJ. Three-Dimensional Modeling of Solid Tumors and Their Microenvironment to Evaluate T Cell Therapy Efficacy In Vitro. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200573

BibTeX
@article{Pscheid2023,
  author = {Pscheid, Ronja and Drent, Esther and Wienke, Judith and Strijker, Josephine G M and Throsby, Mark and Molenaar, Jan J},
  title = {Three-Dimensional Modeling of Solid Tumors and Their Microenvironment to Evaluate T Cell Therapy Efficacy In Vitro},
  journal = {The Journal of Immunology},
  year = {2023},
  doi = {10.4049/jimmunol.2200573}
}
Kostenlos starten →